Page Not Found
The page you are looking for doesn't exist or another error occurred.
Please use the menu above or the search form below to try another section.
Latest News
12th February 2026
NHS changes guidelines for bladder cancer patients following new clinical trial results
Thousands of people with advanced bladder cancer across the UK will now receive three rather than six chemotherapy cycles after Queen Mary University of London-led research led to a change to NHS treatment guidelines. For patients, this means fewer toxic side effects and a better quality of life during treatment.
4th February 2026
Video: Driving Discoveries for Tomorrow’s Cancer Care
Today, on World Cancer Day, join us as we go behind the scenes at Queen Mary’s Barts Cancer Institute (BCI) and meet the people who are making progress possible.
21st January 2026
New approach offers hope for people with rare eye cancer
A more active approach to monitoring and treating people with a rare eye cancer (known as uveal melanoma) that has spread to the liver could help some patients to live longer, according to researchers at Barts Cancer Institute, Queen Mary University of London. The findings, from a retrospective study of the largest UK cohort of patients with this condition to date, offer an encouraging sign of progress in this rare and difficult-to-treat cancer.
17th December 2025
Celebrating the BCI’s highlights of 2025
Join us as we look back at some highlights of Barts Cancer Institute’s news stories this year.
7th November 2025
Discovery reveals new understanding of cancer-driving proteins in rare brain tumours and beyond
Scientists have discovered that a single letter change in a gene called PRKCA drives a rare and hard-to-treat brain cancer, chordoid glioma, through an entirely unexpected mechanism. The findings could open up new ways to design targeted treatments for this difficult-to-treat disease, and possibly for other cancers involving the same gene.
29th October 2025
New spinout launches to advance early pancreatic cancer detection
Queen Mary University of London has launched a new company, Procyon Diagnostics, to provide pioneering early cancer detection tests. The company’s first test, PancRISK, offers new hope for detecting pancreatic cancer earlier, building on over 15 years of research by Professor Tatjana Crnogorac-Jurcevic at Queen Mary’s Barts Cancer Institute (BCI), funded by the Pancreatic Cancer Research Fund.